According to Mayne Pharma Group latest financial reports the total liabilities of MYX is $414.71M, an decrease of -16.12% to 2022. At the end of 2022 company had $494.42M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Mayne Pharma Group is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $414.71M | -16.12% |
2022 | $494.42M | 5.67% |
2021 | $467.90M | -11.66% |
2020 | $529.64M | 58.57% |
2019 | $334.00M | - |